LEALI, Daria
 Distribuzione geografica
Continente #
NA - Nord America 2.534
EU - Europa 1.502
AS - Asia 1.184
SA - Sud America 218
AF - Africa 47
OC - Oceania 5
Totale 5.490
Nazione #
US - Stati Uniti d'America 2.493
PL - Polonia 503
CN - Cina 429
SG - Singapore 352
DE - Germania 279
UA - Ucraina 208
BR - Brasile 182
HK - Hong Kong 121
GB - Regno Unito 105
VN - Vietnam 84
FI - Finlandia 82
RU - Federazione Russa 68
IT - Italia 60
FR - Francia 56
TR - Turchia 42
ES - Italia 37
IE - Irlanda 36
IN - India 34
BD - Bangladesh 23
CA - Canada 22
SE - Svezia 18
CZ - Repubblica Ceca 15
IR - Iran 14
JP - Giappone 13
ZA - Sudafrica 12
MX - Messico 10
AR - Argentina 9
ID - Indonesia 9
KR - Corea 7
MA - Marocco 7
PK - Pakistan 7
CO - Colombia 6
NO - Norvegia 6
EC - Ecuador 5
EG - Egitto 5
ET - Etiopia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AT - Austria 4
AU - Australia 4
CL - Cile 4
IL - Israele 4
LT - Lituania 4
MU - Mauritius 4
NG - Nigeria 4
NL - Olanda 4
PY - Paraguay 4
TH - Thailandia 4
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
BG - Bulgaria 3
DZ - Algeria 3
GE - Georgia 3
IQ - Iraq 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
HN - Honduras 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MY - Malesia 2
PA - Panama 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
MZ - Mozambico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.490
Città #
Warsaw 502
Fairfield 259
Ashburn 235
Woodbridge 192
Singapore 190
Jacksonville 158
Houston 155
Ann Arbor 133
San Jose 127
Hong Kong 114
Beijing 108
Wilmington 106
Seattle 105
Chandler 92
Cambridge 84
Princeton 64
Los Angeles 63
The Dalles 55
Helsinki 50
Nanjing 46
Dearborn 38
New York 38
Dublin 36
Madrid 31
Dallas 30
Lauterbourg 30
Istanbul 29
Jinan 27
Shanghai 24
Brescia 23
San Francisco 23
Dong Ket 21
Council Bluffs 20
Porto Alegre 20
Santa Clara 20
Ho Chi Minh City 19
Des Moines 18
Nanchang 18
Buffalo 16
Shenyang 16
São Paulo 16
Changsha 15
Hebei 14
Jiaxing 14
Brno 13
Chicago 13
Lancaster 13
Orem 13
Hanoi 12
Munich 12
Stockholm 12
Tokyo 12
Brooklyn 11
London 11
Redondo Beach 11
San Mateo 11
Hangzhou 10
Moscow 10
Johannesburg 9
Phoenix 9
Poplar 9
Rio de Janeiro 9
Chennai 8
Kunming 8
Nuremberg 8
San Diego 8
Frankfurt am Main 7
Milan 7
Montreal 7
Nürnberg 7
Jakarta 6
Kilburn 6
Oslo 6
Tianjin 6
Verona 6
Atlanta 5
Bahir Dar 5
Biên Hòa 5
Campinas 5
Haikou 5
Ningbo 5
Tehran 5
Uberlândia 5
Zhengzhou 5
Abuja 4
Ardabil 4
Augusta 4
Bangkok 4
Boardman 4
Denver 4
Glasgow 4
Kocaeli 4
Monmouth Junction 4
Paris 4
Santiago 4
Tashkent 4
Toronto 4
Ankara 3
Baku 3
Baliuag 3
Totale 3.790
Nome #
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 346
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 302
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 298
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 287
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 246
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 226
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 224
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 212
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 204
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 203
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 202
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 198
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 174
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 173
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 146
Fibroblast growth factor-2 in angiogenesis 141
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 141
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 139
Heparin derivatives as angiogenesis inhibitors 135
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 133
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 131
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement. 127
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 127
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement 124
Role of inflammation in FGF2-driven angiogenesis 123
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 108
FGF2- Antagonist activity of long pentraxin-3 107
Heparin derivatives and semysynthetic biotechnological heparins as angiogenesis inhibitors 105
FGF2-Antagonist activity of long pentraxin-3 related peptides 103
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 102
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 99
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 97
Cutting Edge: IL-1beta Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes 93
Totale 5.576
Categoria #
all - tutte 21.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 0 0 0 45 67 42
2021/2022278 6 65 2 1 1 14 16 14 10 51 23 75
2022/2023253 37 11 23 14 14 54 0 26 31 2 20 21
2023/2024333 21 38 41 17 20 26 15 12 62 13 8 60
2024/2025682 16 11 7 85 62 58 72 52 81 33 110 95
2025/20261.345 142 156 103 180 238 95 252 33 66 80 0 0
Totale 5.576